elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26998914-9759D1CC-32A9-48E0-93A8-549A05ABBBA9
Q26998914-9759D1CC-32A9-48E0-93A8-549A05ABBBA9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26998914-9759D1CC-32A9-48E0-93A8-549A05ABBBA9
Tyrosine kinase inhibitors induced thyroid dysfunction: a review of its incidence, pathophysiology, clinical relevance, and treatment
P2860
Q26998914-9759D1CC-32A9-48E0-93A8-549A05ABBBA9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26998914-9759D1CC-32A9-48E0-93A8-549A05ABBBA9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
79cde3160f5ca24f66305f2d7fa1c02dec358e66
P2860
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer